FindTrial
Sign In

Efficacy of Gomutra-Haritaki and Guda-Haritaki in the management of Jalodara With Special Reference Ascites of Hepatic Cirrhosis Origin - An open labeled randomized comparative clinical trial.

Efficacy of Gomutra-Haritaki and Guda-Haritaki in the management of Jalodara W.S.R. Ascites of Hepatic Cirrhosis Origin - An open labeled randomized comparative clinical trial. - No

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032209
Enrollment
30
Registered
2021-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K703- Alcoholic cirrhosis of liver

Interventions

Intervention1: Internal Administration of Gomutra Haritaki and Guda Haritaki: There are two group in the study one group of 15 patients is given internal administratiom of Gomutra Haritaki 3 to 10 gm

Sponsors

Government Akhandanand Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having ascites due to Hepatic Cirrhosis origin Chronicity less than 1 year Uncomplicated cases of Jalodara Patients willing to participate in trial

Exclusion criteria

Exclusion criteria: Patients having age below 18 years and above 60 years AIDS Congestive Cardiac Failure Congestive Pericarditis Other Cardiac Disorders TB Nephrotic Syndrome Grade 4 prolapsed hemorrhoid Carcinoma Hepatic Encephalopathy Diabetic ketoacidosis Hepatitis B Acute and Chronic Renal Failure Acute Pancreatitis History of Recurrent Gastric and Esophageal Variceal Rupture and Hematemesis Associated with any other serious systemic disease or complications which leads to fatal conditions will be excluded

Design outcomes

Primary

MeasureTime frame
Result will be assessed on the basis of relief signs and symptoms of Jalodara after 6 weeks.Timepoint: Result will be assessed on the basis of relief signs and symptoms of Jalodara after 6 weeks.—

Secondary

MeasureTime frame
By comparing the effect of both drugs in the management of jalodaraTimepoint: 6 weeks—

Countries

India

Contacts

Public ContactSurendra A Soni

Government Akhandanand Ayurved Mahavidyalaya

surendraasoni@gmail.com9408441150

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026